MedTrace Logo

Improving Employment and Reducing Recidivism Among Prison Offenders Via Virtual Interview Training Tool (MICHR)

NCT04140942 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-01-25

Study results available
· View outcomes & findings →

Summary

The goal is to conduct a feasibility effectiveness RCT of Virtual Interview Training (VIT) by comparing employment and recidivism outcomes of offenders (25 years and older) receiving vocational services as usual (SAU) plus VIT (SAU+VIT) with the outcomes of offenders receiving only services as usual (SAU-only).

The plan calls for participants to include offenders who are at moderate to high risk for reoffending (with an emphasis on violent-crime reoffending) who are currently enrolled in a Vocational Village Prison Setting with the Michigan Department of Corrections.

Conditions

  • Criminal Behavior

Interventions

BEHAVIORAL

Virtual Reality Job Interview Training

Participants will engage in training related to preforming well during a job interview as well as repeated job interview practice with a virtual hiring manager. Participants will receive feedback and tips on improving skills throughout training.

BEHAVIORAL

Services as usual

Study participants will be receiving Vocational Village services as usual that may include but is not limited to vocational skill training, daily living skill training, and social skill training.

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • University of Michigan

    lead OTHER

Principal Investigators

  • Matthew J Smith, PhD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-06
Primary Completion
2021-07-20
Completion
2021-07-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04140942 on ClinicalTrials.gov